Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

The Medicines Company to Participate in RBC Capital Markets' Healthcare Conference


Print article Print article
© Marketwire 2013
2013-02-22 22:47:38 -

PARSIPPANY, NJ -- (Marketwire) -- 02/22/13 -- The Medicines Company (NASDAQ: MDCO) will present at the 2013 RBC Capital Markets' Healthcare Conference on Tuesday, February 26 in a question and answer session from 09:30 to 09:55 am.





The session will be webcast with a link available at The Medicines Company's website http://www.themedicinescompany.com : www.themedicinescompany.com/ .



About The Medicines Company
The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is www.themedicinescompany.com : www.themedicinescompany.com/ .



Add to Digg : digg.com/submit?phase=2&url= www2.marketwire.com/mw/release_html_b1?release_id=989327 Bookmark with del.icio.us : del.icio.us/post?v=4&noui&jump=close&url= www2.marketwire.com/mw/release_html_b1?release_id=989327 Add to Newsvine : www.newsvine.com/_tools/seed&save?u= www2.marketwire.com/mw/release_html_b1?release_id=989327




Contact:
Michael Mitchell
The Medicines Company
973-290-6000
investor.relations@themedco.com : docid: 13989327.nitf -->



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com